Founded in 2017, the firm is led by Dr. Marijn E. Dekkers, former CEO of Bayer AG and Thermo Fisher Scientific Inc. Novalis works with a diverse group of specialists in life science fields, investing in small to medium-sized companies in drug discovery, diagnostics, genetics, and other biotechnology sectors.